Pfizer looks to maintain innovation lead in Japan
This article was originally published in Scrip
Executive Summary
Pfizer is aiming for at least six product approvals every year in Japan, building on what it says is an industry-leading record of innovation in the country and a well-stocked local clinical pipeline.